BioMarin announces five-year Phase 3 data for Pombiliti, Opfolda
BioMarin said it will present five-year Phase 3 data for Pombiliti (cipaglucosidase alfa-atga) and Opfolda (miglustat) at the World Muscle Society Annual Congress.
BioMarin said it will present five-year Phase 3 data for Pombiliti (cipaglucosidase alfa-atga) and Opfolda (miglustat) at the World Muscle Society Annual Congress.